AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ATOMO DIAGNOSTICS LTD

0.041

0.000

Volume:317.26K

Turnover:12.55K

Market Cap:33.22M

PE:-5.34

High:0.041

Open:0.040

Low:0.039

Close:0.041

52wk High:0.048

52wk Low:0.014

Shares:810.18M

Float Shares:423.51M

Volume Ratio:0.08

T/O Rate:0.07%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.008

EPS(LYR):-0.008

ROE:-58.27%

ROA:-35.32%

PB:4.76

PE(LYR):-5.34

Loading ...

Overview Company News Filings

BRIEF-Atomo Diagnostics Secures Exclusive Licence For Novel Liver Function Test On Pascal

BUZZ-Australia's Atomo Diagnostics jumps on new liver test license

Atomo Diagnostics - Agreement With Burnet Diagnostics Initiative

THOMSON REUTERS

Atomo Diagnostics - Exclusive Licence for a Novel Liver Function Test on Pascal

THOMSON REUTERS

BRIEF-Atomo Diagnostics Secures A$502,000 Order For HIV Self-Tests

BUZZ-Australia's Atomo Diagnostics rises on supply order

Atomo Diagnostics Ltd - Secures a$502,000 Order for Hiv Self-Tests

THOMSON REUTERS

Atomo Diagnostics Insider Confidence Rewarded, Stock Hits AU$28m Market Cap

Simply Wall St.

Atomo Diagnostics Ltd-Chair's Address to Shareholders

THOMSON REUTERS

BRIEF-Atomo Diagnostics Appoints Patrick Cook As Independent Chair

Atomo Diagnostics Appoints Chair

MT Newswires Live

Atomo Diagnostics - Appoints Patrick Cook as Independent Chair

THOMSON REUTERS

S&P Rates Mitsubishi UFJ Financial Group's AT1 Notes BB+

MT Newswires Live

BRIEF-Atomo Diagnostics Posts FY Loss Attributable Of A$4.9 Million

Atomo Diagnostics Ltd - FY Revenue a$3.8 Mln

THOMSON REUTERS

Atomo Diagnostics Flags Pascal Test Cassette's Performance in Lumos' Test of Diagnostic Product

MT Newswires Live

BRIEF-Atomo Diagnostics Seeks Trading Halt For Material Supply Contract Announcement

Atomo Diagnostics Ltd - Seeks Trading Halt for Material Supply Contract Announcement

THOMSON REUTERS

Atomo Secures $410,000 Order From Lumos to Support FebriDx Rollout in US; Shares Down 5%

MT Newswires Live

BRIEF-Atomo Diagnostics Posts Unaudited Revenue A$1.07M In Q4 FY25

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AT1.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"AT1.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AT1.AU\",,,,,undefined,":{"symbol":"AT1.AU","market":"AU","secType":"STK","nameCN":"ATOMO DIAGNOSTICS LTD","latestPrice":0.041,"timestamp":1770786720000,"preClose":0.041,"halted":0,"volume":317261,"delay":0,"changeRate":0,"nameEN":"ATOMO DIAGNOSTICS LTD","floatShares":423507786,"shares":810175282,"eps":-0.007681,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-11 16:12:00 AEDT","open":0.04,"high":0.041,"low":0.039,"amount":12545,"amplitude":0.04878,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.007681,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770850800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.041,"openAndCloseTimeList":[[1770764400000,1770786000000]],"volumeRatio":0.07986194494411494,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AT1.AU\",,,,,undefined,":{"symbol":"AT1.AU","floatShares":423507786,"roa":"-35.32%","roe":"-58.27%","lyrEps":-0.007681,"volumeRatio":0.07986194494411494,"shares":810175282,"dividePrice":0,"high":0.041,"amplitude":0.04878,"preClose":0.041,"low":0.039,"week52Low":0.014,"pbRate":"4.76","psRate":"8.76","week52High":0.048,"institutionHeld":0,"latestPrice":0.041,"eps":-0.007681,"divideRate":0,"volume":317261,"delay":0,"ttmEps":-0.007681,"open":0.04,"prevYearClose":0.036,"prevWeekClose":0.04,"prevMonthClose":0.038,"prevQuarterClose":0.036,"fiveDayClose":0.042,"twentyDayClose":0.036,"sixtyDayClose":0.027},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AT1.AU\",params:#limit:5,,,undefined,":[{"date":"2026-01-27","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769468400000,"name":null,"time":"","dateTimestamp":1769432400000,"actualEps":null},{"date":"2025-10-28","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761606000000,"name":null,"time":"","dateTimestamp":1761570000000,"actualEps":null},{"date":"2025-08-29","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-07-29","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753747200000,"name":null,"time":"","dateTimestamp":1753711200000,"actualEps":null},{"date":"2025-04-24","symbol":"AT1.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1745452800000,"name":null,"time":"","dateTimestamp":1745416800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AT1.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AT1.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2604302152","title":"BRIEF-Atomo Diagnostics Secures Exclusive Licence For Novel Liver Function Test On Pascal","url":"https://stock-news.laohu8.com/highlight/detail?id=2604302152","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604302152?lang=en_us&edition=fundamental","pubTime":"2026-01-20 09:15","pubTimestamp":1768871707,"startTime":"0","endTime":"0","summary":"BRIEF-Atomo Diagnostics Secures Exclusive Licence For Novel Liver Function Test On PascalJan 20  - Atomo Diagnostics Ltd AT1.AX:EXCLUSIVE LICENCE FOR A NOVEL LIVER FUNCTION TEST ON PASCALAGREEMENT WITH BURNET DIAGNOSTICS INITIATIVEFurther company coverage: AT1.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YK0KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","BK7501","AT1.AU"],"gpt_icon":0},{"id":"2604154385","title":"BUZZ-Australia's Atomo Diagnostics jumps on new liver test license","url":"https://stock-news.laohu8.com/highlight/detail?id=2604154385","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604154385?lang=en_us&edition=fundamental","pubTime":"2026-01-20 08:40","pubTimestamp":1768869631,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Atomo Diagnostics jumps on new liver test license** Atomo Diagnostics AT1.AX jumps 11.4% to A$0.039; set for strongest trading session since December 9, 2025** Medical devices co signs exclusive global licensing agreement with Burnet Diagnostics Initiative for novel liver function test** Says license for Burnet's liver function test supports commercialisation of rapid test for immediate detection of liver injury** Test can be administered via co's self-testing device Pascal cassette** YTD, AT1 up 5.6%; had risen 89.5% in 2025  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL6N3YL01I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","BK7501","AT1.AU"],"gpt_icon":0},{"id":"2604568961","title":"Atomo Diagnostics - Agreement With Burnet Diagnostics Initiative","url":"https://stock-news.laohu8.com/highlight/detail?id=2604568961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604568961?lang=en_us&edition=fundamental","pubTime":"2026-01-20 06:31","pubTimestamp":1768861901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nFWN3YK0KK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AT1.AU","BK7501","BK7007"],"gpt_icon":0},{"id":"2604156893","title":"Atomo Diagnostics - Exclusive Licence for a Novel Liver Function Test on Pascal","url":"https://stock-news.laohu8.com/highlight/detail?id=2604156893","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604156893?lang=en_us&edition=fundamental","pubTime":"2026-01-20 06:31","pubTimestamp":1768861901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nFWN3YK0KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","AT1.AU","BK7007"],"gpt_icon":0},{"id":"2603627798","title":"BRIEF-Atomo Diagnostics Secures A$502,000 Order For HIV Self-Tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2603627798","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603627798?lang=en_us&edition=fundamental","pubTime":"2026-01-15 11:53","pubTimestamp":1768449215,"startTime":"0","endTime":"0","summary":"BRIEF-Atomo Diagnostics Secures A$502,000 Order For HIV Self-TestsJan 15 (Reuters) - Atomo Diagnostics Ltd AT1.AX:SECURES A$502,000 ORDER FOR HIV SELF-TESTSFurther company coverage: AT1.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YF1VY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AT1.AU","BK7007","BK7501"],"gpt_icon":0},{"id":"2603623968","title":"BUZZ-Australia's Atomo Diagnostics rises on supply order","url":"https://stock-news.laohu8.com/highlight/detail?id=2603623968","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603623968?lang=en_us&edition=fundamental","pubTime":"2026-01-15 08:12","pubTimestamp":1768435962,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Atomo Diagnostics rises on supply order** Shares of Atomo Diagnostics AT1.AX rise as much as 13.5% to A$0.042, their highest level since January 5** Stock logs its biggest intraday pct gain since January 2** The medical device firm secures purchase order for A$502,000  worth of HIV self-tests** Adds that supply order is for an African country** Stock set for a third consecutive session of gains, if current momentum persists** Stock up nearly 90% in 2025       ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nL4N3YG005:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","AT1.AU","BK7007"],"gpt_icon":0},{"id":"2603647882","title":"Atomo Diagnostics Ltd - Secures a$502,000 Order for Hiv Self-Tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2603647882","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603647882?lang=en_us&edition=fundamental","pubTime":"2026-01-15 05:54","pubTimestamp":1768427642,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF1VY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","AT1.AU","BK7501"],"gpt_icon":0},{"id":"2588070781","title":"Atomo Diagnostics Insider Confidence Rewarded, Stock Hits AU$28m Market Cap","url":"https://stock-news.laohu8.com/highlight/detail?id=2588070781","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588070781?lang=en_us&edition=fundamental","pubTime":"2025-12-04 06:57","pubTimestamp":1764802640,"startTime":"0","endTime":"0","summary":"Insiders who bought Atomo Diagnostics Limited ( ASX:AT1 ) stock in the last 12 months were richly rewarded last week...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-at1/atomo-diagnostics-shares/news/atomo-diagnostics-insider-confidence-rewarded-stock-hits-au2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-at1/atomo-diagnostics-shares/news/atomo-diagnostics-insider-confidence-rewarded-stock-hits-au2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","BK7501","AT1.AU"],"gpt_icon":0},{"id":"2579310573","title":"Atomo Diagnostics Ltd-Chair's Address to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2579310573","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579310573?lang=en_us&edition=fundamental","pubTime":"2025-10-31 05:55","pubTimestamp":1761861322,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUE5WL3D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","AT1.AU","BK7501"],"gpt_icon":0},{"id":"2566651370","title":"BRIEF-Atomo Diagnostics Appoints Patrick Cook As Independent Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2566651370","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566651370?lang=en_us&edition=fundamental","pubTime":"2025-09-09 09:22","pubTimestamp":1757380952,"startTime":"0","endTime":"0","summary":"BRIEF-Atomo Diagnostics Appoints Patrick Cook As Independent ChairSept 9 (Reuters) - Atomo Diagnostics Ltd AT1.AX:APPOINTS PATRICK COOK AS INDEPENDENT CHAIRFurther company coverage: AT1.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nFWN3UV1F4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7007","AT1.AU"],"gpt_icon":0},{"id":"2566651351","title":"Atomo Diagnostics Appoints Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2566651351","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566651351?lang=en_us&edition=fundamental","pubTime":"2025-09-09 09:17","pubTimestamp":1757380633,"startTime":"0","endTime":"0","summary":"Atomo Diagnostics (ASX:AT1) appointed Patrick Cook as independent chair of the board, according to a Tuesday filing with the Australian bourse.Cook will succeed interim Chairman John Kelly, who will now focus on his role as managing director, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","BK7501","XKO.AU","XJO.AU","BK7007","AT1.AU"],"gpt_icon":0},{"id":"2566465374","title":"Atomo Diagnostics - Appoints Patrick Cook as Independent Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2566465374","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566465374?lang=en_us&edition=fundamental","pubTime":"2025-09-09 07:47","pubTimestamp":1757375231,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nFWN3UV1F4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","BK7501","AT1.AU"],"gpt_icon":0},{"id":"2564367825","title":"S&P Rates Mitsubishi UFJ Financial Group's AT1 Notes BB+","url":"https://stock-news.laohu8.com/highlight/detail?id=2564367825","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564367825?lang=en_us&edition=fundamental","pubTime":"2025-09-03 18:50","pubTimestamp":1756896634,"startTime":"0","endTime":"0","summary":"S&P Global Ratings has given Mitsubishi UFJ Financial Group's  $1 billion perpetual, subordinated additional tier one  notes a BB+ long-term issue credit rating, according to a Wednesday release.The issuance complies with Basel III rules under Japan's requirements, according to S&P.The AT1 notes' rating is five notches under S&P's \"a\" standalone credit profile for the group, since extraordinary government support would be unlikely.The notes have intermediate equity content, which further anchors S&P's view that the issuer will maintain steady capitalization in the next one to two years.The issuance should also buoy the banks' diversification efforts for its long-term foreign currency funding profile amid rising overseas lending demands.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","AT1.AU","BK4207","MUFG","BK7501"],"gpt_icon":0},{"id":"2563209932","title":"BRIEF-Atomo Diagnostics Posts FY Loss Attributable Of A$4.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2563209932","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563209932?lang=en_us&edition=fundamental","pubTime":"2025-08-29 09:45","pubTimestamp":1756431940,"startTime":"0","endTime":"0","summary":"BRIEF-Atomo Diagnostics Posts FY Loss Attributable Of A$4.9 MillionAug 29 (Reuters) - Atomo Diagnostics Ltd AT1.AX:FY LOSS ATTRIBUTABLE A$4.9 MILLIONFY REVENUE A$3.8 MILLIONFurther company coverage: AT1.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nFWN3UK1SR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7007","AT1.AU"],"gpt_icon":0},{"id":"2563060972","title":"Atomo Diagnostics Ltd - FY Revenue a$3.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2563060972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563060972?lang=en_us&edition=fundamental","pubTime":"2025-08-29 07:31","pubTimestamp":1756423892,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nFWN3UK1SR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7007","AT1.AU"],"gpt_icon":0},{"id":"2561451880","title":"Atomo Diagnostics Flags Pascal Test Cassette's Performance in Lumos' Test of Diagnostic Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2561451880","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561451880?lang=en_us&edition=fundamental","pubTime":"2025-08-21 15:07","pubTimestamp":1755760026,"startTime":"0","endTime":"0","summary":"Atomo Diagnostics  said that its Pascal test cassette performed \"exceptionally well\" in US clinical studies supporting a Clinical Laboratory Improvement Amendments  waiver submission for a test of Lumos Diagnostics Holdings'  product, FebriDx, according to a Thursday Australian bourse filing.FebriDx secured a 510k clearance from the US Food and Drug Administration using the Pascal cassette and recently completed a CLIA waiver trial and submission to the FDA using the Pascal cassette.The FebriDx test uses Atomo's Pascal test cassette to deliver improved usability and reliability in point-of-care settings, and Atomo is the exclusive licensor, manufacturer, and supplier of the cassettes to Lumos.Atomo and Lumos are now in talks regarding the supply of Pascal cassettes for the PHASE agreement.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LDX.AU","CLIA","BK7501","AT1.AU","BK7126","BK7007"],"gpt_icon":0},{"id":"2560130002","title":"BRIEF-Atomo Diagnostics Seeks Trading Halt For Material Supply Contract Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2560130002","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560130002?lang=en_us&edition=fundamental","pubTime":"2025-08-19 09:24","pubTimestamp":1755566664,"startTime":"0","endTime":"0","summary":"BRIEF-Atomo Diagnostics Seeks Trading Halt For Material Supply Contract AnnouncementAug 19 (Reuters) - Atomo Diagnostics Ltd AT1.AX:SEEKS TRADING HALT FOR MATERIAL SUPPLY CONTRACT ANNOUNCEMENTFurther company coverage: AT1.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nFWN3UA0L9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","AT1.AU","BK7007"],"gpt_icon":0},{"id":"2560329791","title":"Atomo Diagnostics Ltd - Seeks Trading Halt for Material Supply Contract Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2560329791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560329791?lang=en_us&edition=fundamental","pubTime":"2025-08-19 08:21","pubTimestamp":1755562893,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nFWN3UA0L9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","AT1.AU","BK7501"],"gpt_icon":0},{"id":"2557538323","title":"Atomo Secures $410,000 Order From Lumos to Support FebriDx Rollout in US; Shares Down 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557538323","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557538323?lang=en_us&edition=fundamental","pubTime":"2025-08-07 12:11","pubTimestamp":1754539860,"startTime":"0","endTime":"0","summary":"Atomo Diagnostics  said its strategic partner Lumos Diagnostics   placed an order with the company for the supply of $410,000 worth of Pascal cassettes to support scaling up the demand for the company's diagnostic product, FebriDx, in the US market, according to a Thursday Australian bourse filing.The company said that Lumos indicated that it expects the agreement with Phase to generate FebriDx product sales of up to $316 million over six years, assuming that the clinical laboratory improvement amendments  waiver is granted and contracted minimum order quantities are achieved.The FebriDx test secured a 510k clearance from the US Food and Drug Administration and is currently well progressed through a CLIA waiver study that is expected to be completed this month.Atomo Diagnostics' shares fell 5% in recent Thursday trade. Lumos Diagnostics' shares jumped almost 6%, earlier hitting their highest since September 2023.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LDX.AU","BK7007","BK7126","AT1.AU","CLIA","BK7501"],"gpt_icon":0},{"id":"2555088755","title":"BRIEF-Atomo Diagnostics Posts Unaudited Revenue A$1.07M In Q4 FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2555088755","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555088755?lang=en_us&edition=fundamental","pubTime":"2025-07-29 09:39","pubTimestamp":1753753165,"startTime":"0","endTime":"0","summary":"BRIEF-Atomo Diagnostics Posts Unaudited Revenue A$1.07M In Q4 FY25July 29 (Reuters) - Atomo Diagnostics Ltd AT1.AX:UNAUDITED REVENUE A$1.07M IN Q4 FY25Further company coverage: AT1.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250729:nFWN3TP249:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AT1.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}